By inducing RANKL expression, IL-17 severely disrupts the RANKL/OPG balance, leading to increased production of osteoclasts and bone erosion in conditions such as arthritis and other bone-related diseases, ultimately resulting in skeletal lesions [51,118]. The gene discussed is TNFSF11; the disease is arthritic joint disease.